CS
TEVA icon

Credential Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Credential Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,273
Closed -$264K – 281
2016
Q4 		$264K Sell
7,273
-1,019
-12% -$40.7K 0.11% 149
2016
Q3 		$382K Sell
8,292
-1,560
-16% -$81.4K 0.17% 131
2016
Q2 		$495K Buy
9,852
+224
+2% +$11.9K 0.26% 111
2016
Q1 		$515K Buy
9,628
+531
+6% +$31.2K 0.3% 102
2015
Q4 		$597K Buy
9,097
+557
+7% +$34.4K 0.39% 86
2015
Q3 		$482K Hold
8,540
– – 0.34% 94
2015
Q2 		$505K Buy
8,540
+1,741
+26% +$107K 0.32% 99
2015
Q1 		$424K Buy
6,799
+365
+6% +$21.2K 0.28% 102
2014
Q4 		$370K Buy
+6,434
New +$358K 0.24% 110

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credential Securities's TEVA Position: Q1 2017 in Review

Credential Securities sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 7,273 shares — an estimated $264K sold.

Credential Securities first reported a position in TEVA in Q4 2014 and held it in 9 quarters. The position peaked at $597K in Q4 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Credential Securities reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Credential Securities sold 7,273 Teva Pharmaceuticals shares in Q1 2017, an estimated $264K.
  • Credential Securities first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 9 quarters.
  • Credential Securities's Teva Pharmaceuticals position peaked at $597K in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Credential Securities's 13F filing for Q1 2017, filed 21 Jul 2025.